Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call
August 01 2024 - 7:00AM
Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology
company that develops and licenses plant traits to seed companies
for royalties, today announced that the company will report second
quarter 2024 financial results on Thursday, August 8, 2024. Cibus’
management team will host a conference call and audio webcast at
4:30 p.m. ET on that day to discuss the financial results and other
company updates.
Title: Cibus, Inc. Second Quarter 2024 Results Conference Call
Event Date: Thursday, August 8,
2024 Time: 4:30
p.m. ET Participant
Numbers: +1-800-343-5172 (U.S.), +1-203-518-9856
(International)The conference ID “CIBUS” or 24287 will be
required for
entry
Event Link: https://investor.cibus.com/events
For interested individuals unable to join the conference call, a
dial-in replay of the call will be available through Thursday,
August 22, 2024 and can be accessed by dialing +1-844-512-2921
(U.S.), +1-412-317-6671 (International) and entering replay
passcode: 11156392.
A live audio webcast of the call, along with accompanying
slides, will be available under "News & Events” in the Investor
section of the Company's website, investor.cibus.com. An archived
webcast will be available on the Company's website for 90 days
after the event.
About Cibus Cibus is a leader in gene edited
productivity traits that address critical productivity and
sustainability challenges for farmers such as diseases and pests
which the United Nations estimates cost the global economy
approximately $300 billion annually. Cibus is not a seed company.
It is a technology company that uses gene editing to develop and
license traits to seed companies in exchange for royalties on seed
sales. Cibus' focus is productivity traits for farmers for the
major global row crops with large acreage such as canola, corn,
rice, soybean, and wheat. Cibus is a technology leader in high
throughput gene editing technology that enables Cibus to develop
and commercialize plant traits at a fraction of the time and cost
of conventional breeding. Cibus has developed a pipeline of five
productivity traits including important traits for Pod Shatter
Reduction, Sclerotinia (disease) resistance, and weed management.
Its initial traits for Pod Shatter Reduction and weed management
are in commercial development with leading seed companies such as
Nuseed Americas Inc. in Canola as well as Nutrien Ltd. and Interoc
S.A. in Rice in the United States and Latin America. Its other
pipeline traits including Sclerotinia resistance are in advanced
greenhouse and field trial stages.
Cibus Contacts: Investor
RelationsKaren Troeberktroeber@cibus.com 858-450-2636
Jeff Sonnek – ICRjeff.sonnek@icrinc.com
Media RelationsColin Sanford
colin@bioscribe.com 203-918-4347
Cibus (NASDAQ:CBUS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cibus (NASDAQ:CBUS)
Historical Stock Chart
From Oct 2023 to Oct 2024